
Last updated: 2026-09-16 09:46:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Black Hawk Acquisition Corporation (BKHA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $11.93, with a market capitalisation of $49.53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.00 to $13.10. This page covers its latest market performance, valuation, price trends and company information.
$49.53M | |
$11.79 | |
$13.10 | |
$10.09 | |
-- | |
12.00 | |
2.56K | |
-- | |
$13.10 | |
$11.00 | |
-- | |
-- |
Black Hawk Acquisition Corporation (BKHA) is trading at $-- in pre-market trading as of 2026-09-15 14:47:00, -- from the previous close of $0.00
Pre-market trading shows how investors are pricing BKHA before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Black Hawk Acquisition Corporation (BKHA) moved from $11.89 to $11.93, representing a gain of 0.29% ($0.04).
The stock traded between $11.79 and $11.99 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 650.34 shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 44.0%
BKHA is currently trading at $11.93, placing it 44.0% of the way from its 52-week low of $11.00 to its 52-week high of $13.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Black Hawk Acquisition Corp is a Blank check company.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Black Hawk Acquisition Corporation (BKHA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.